Skip to content

SR 201 · Kentucky · 2026RS · Billy

Skip to content

Home
/
Bills
/
Kentucky
/
2026RS
/
SR 201

Kentucky · 2026RS session · senate

SR 201A RESOLUTION encouraging Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in Kentucky.

Status: Passed chamber
Latest action: 2026-04-01 — adopted by voice vote
Primary sponsor: S. Funke Frommeyer

Drugs and Medicines
Economic Development
Science and Technology

Track this bill View changes

Sponsors

S. Funke Frommeyer · primaryprimary
R. Stivers · primaryprimary

Versions

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pages Compare Billy Kentucky bill RSS

Current/FinalMar 26, 2026

IntroducedMar 26, 2026

Legislative history

Apr 1, 2026
adopted by voice vote
Mar 31, 2026
to Senate Floor
Mar 26, 2026
to Committee on Committees (S)
Mar 26, 2026
introduced in Senate

Official sources

Version 0PDF
Version 1PDF

About this page

Is this the official Kentucky bill page?: No — this is Billy’s public legislative record for SR 201. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track SR 201, get alerts, annotate diffs, and export Word work product.